\u767e\u6d4e\u795e\u5dde\uff08NASDAQ\uff1aBGNE\uff09<\/a>\u548c\u764c\u75c7\u5408\u4f5c\u4f19\u4f34\u5b89\u8fdb\uff08NASDAQ\uff1aAMGN\uff09<\/a>\u8868\u793a\uff0c\u7531\u4e8e\u884c\u4f7f\u671f\u6743\u548c\u9650\u5236\u6027\u80a1\u7968\u5355\u4f4d\u800c\u5bfc\u81f4\u6d41\u901a\u80a1\u6570\u91cf\u589e\u52a0\uff0c\u6240\u4ee5\u540c\u610f\u767e\u6d4e\u795e\u5dde\u540c\u610f\u5b89\u8fdb\u62e5\u6709\u66f4\u591a\u80a1\u4efd\uff0c\u4f7f\u5b89\u8fdb\u4fdd\u630120.5%\u7684\u80a1\u6743\u6bd4\u4f8b\u3002<\/p>\n \u5728\u4e00\u4efd\u58f0\u660e\u4e2d\uff0cAlexion Pharmaceuticals\uff08NASDAQ\uff1aALXN\uff09<\/a>\u8bf4\uff0c\u5b83\u5df2\u7ecf\u5efa\u7acb\u4e86\u201c\u575a\u5b9e\u7684\u57fa\u7840\u201d\u6765\u63a8\u52a8\u589e\u957f\u5e76\u63d0\u9ad8\u80a1\u4e1c\u4ef7\u503c\uff0c\u5e76\u4e14\u4e0d\u6253\u7b97\u6309\u7167\u80a1\u4e1cElliott Advisors\u7684\u63d0\u8bae\u8fdb\u884c\u76f4\u63a5\u51fa\u552e\u3002<\/p>\n \u7ba1\u7406\u5c42\u5f15\u7528\u5b8c\u5584\u7684\u7b56\u7565\uff0c\u5c06\u73b0\u6709\u8d44\u4ea7\u6269\u5c55\u5230\u65b0\u75be\u75c5\u4e2d\uff0c\u5e76\u6539\u8fdb\u4e86\u4ea7\u54c1\u7ebf\u3002\u8be5\u516c\u53f8\u80a1\u4ef7\u4e0a\u6da8\u4e866%\u3002<\/p>\n Gemphire Therapeutics\uff08NASDAQ\uff1aGEMP\uff09<\/a>\u7684\u80a1\u4e1c\u5df2\u6279\u51c6\u6240\u6709\u4e0eNeuroBo\u5408\u5e76\u76f8\u5173\u7684\u63d0\u8bae\uff0c\u5305\u62ec\uff1a\uff08i\uff09\u6839\u636e7\u670824\u65e5\u7684\u534f\u8bae\u53d1\u884cGemphire\u666e\u901a\u80a1\uff0c\uff08ii\uff09Gemphire\u666e\u901a\u80a1\u7684\u53cd\u5411\u80a1\u7968\u5206\u5272\uff1b\u5e76\u4e14\uff08iii\uff09\u5c06\u540d\u79f0\u4ece\u201c Gemphire Therapeutics\u201d\u66f4\u6539\u4e3a\u201c NeuroBo Pharmaceuticals\uff0cInc.\u201d<\/p>\n \u4ea4\u6613\u5b8c\u6210\u540e\uff0c\u516c\u53f8\u80a1\u7968\u6709\u671b\u5728\u7eb3\u65af\u8fbe\u514b\u5f00\u59cb\u4ea4\u6613\uff0c\u80a1\u7968\u4ee3\u7801\u4e3a\u201c NRBO\u201d\u3002<\/p>\n FDA\u5c06\u5f3a\u751f\u516c\u53f8\uff08NYSE\uff1aJNJ\uff09<\/a>\u65d7\u4e0b\u6768\u68ee\u5236\u836f\u7684CAR T\u5019\u9009\u836f\u7269JNJ-682284528\uff08JNJ-4528\uff09\u6307\u5b9a\u4e3a\u6cbb\u7597\u590d\u53d1\/\u96be\u6cbb\u6027\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u7684\u7a81\u7834\u6027\u7597\u6cd5\u3002<\/p>\n \u7a81\u7834\u6027\u6cbb\u7597\u72b6\u6001\u4e3aFDA\u63d0\u4f9b\u4e86\u5173\u4e8e\u5f00\u53d1\u7684\u66f4\u6df1\u5165\u7684\u6307\u5bfc\uff0c\u66f4\u591a\u9ad8\u7ea7\u673a\u6784\u4eba\u5458\u7684\u53c2\u4e0e\u4ee5\u53ca\u5bf9\u8425\u9500\u7533\u8bf7\u7684\u52a0\u901f\u5ba1\u67e5\u3002<\/p>\n bluebird bio\uff08NASDAQ\uff1aBLUE\uff09<\/a>\u548c\u88ab\u8bb8\u53ef\u65b9\u767e\u65f6\u7f8e\u65bd\u8d35\u5b9d\uff08NYSE\uff1aBMY\uff09<\/a>\u5ba3\u5e03\u4e86\u4e00\u98792\u671f\u4e34\u5e8a\u8bd5\u9a8cKarMMa\u7684\u79ef\u6781\u7ed3\u679c\uff0c\u8be5\u7ed3\u679c\u8bc4\u4f30\u4e86CAR T\u7597\u6cd5bb2121\u5bf9\u8010\u591a\u836f\u9aa8\u9ad3\u7624\uff08MM\uff09\u60a3\u8005\u7684\u7597\u6548\u3002<\/p>\n \u8be5\u7814\u7a76\u7b26\u5408\u4e3b\u8981\u548c\u4e3b\u8981\u6b21\u8981\u7ec8\u70b9\u3002\u5177\u4f53\u800c\u8a00\uff0c\u4e09\u5242\uff08\u4e3b\u8981\u7ec8\u70b9\uff09\u7684\u603b\u7f13\u89e3\u7387\uff08ORR\uff09\u4e3a73.4%\uff08n = 94\/128\uff09\u3002\u7f13\u89e3\u7387\u4e0e\u5242\u91cf\u6709\u5173\uff0c\u4e3a50.0%\uff08n = 2\/4\uff09\u6700\u4f4e\uff0c\u4e2d\u95f4\u4e3a68.6%\uff08n = 48\/70\uff09\uff0c\u6700\u9ad8\u4e3a81.5%\uff08n = 44\/54\uff09\u3002\u5b8c\u5168\u56de\u5e94\u7387\u5206\u522b\u4e3a25%\u300128.6%\u548c35.2%\u3002 \u4e24\u5bb6\u516c\u53f8\u80a1\u4ef7\u5747\u4e0a\u6da81%\u3002<\/p>\n","protected":false},"excerpt":{"rendered":" Citing an increase in the number of outstanding shares due to option exercises and vesting of restricted share units, BeiGene (NASDAQ:BGNE) and cancer collaboration partner Amgen (NASDAQ:AMGN) have agreed to increase the number of shares allowable to the latter in order for it to maintain its 20.5% stake.<\/p>\n","protected":false},"author":9,"featured_media":308815,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[427],"tags":[820,925,459],"class_list":["post-308819","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hans","tag-820","tag-925","tag-459","sectors-life-science-zh-hans","locations-us-zh-hans","exchange-nasdaq-zh-hans","exchange-nyse-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/308819","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=308819"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/308819\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/308815"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=308819"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=308819"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=308819"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Alexion\u5bf9\u73b0\u72b6\u5145\u6ee1\u4fe1\u5fc3\uff0c\u672a\u8ba1\u5212\u51fa\u552e<\/h2>\n
Gemphire\u7684\u80a1\u4e1c\u6279\u51c6NeuroBo\u5408\u5e76\u63d0\u6848<\/h2>\n
FDA\u52a0\u901f\u5ba1\u67e5\u5f3a\u751fCAR T\u836f\u7269<\/h2>\n
\u767e\u65f6\u7f8e\u65bd\u8d35\u5b9d\u548cbluebird bio\u7684CAR T\u7597\u6cd5\u53d6\u5f97\u6210\u529f<\/h2>\n
\n\u4e2d\u4f4d\u53cd\u5e94\u6301\u7eed\u65f6\u95f4\u4e3a10.6\u4e2a\u6708\uff0c\u4e2d\u4f4d\u65e0\u8fdb\u5c55\u751f\u5b58\u671f\u4e3a8.6\u4e2a\u6708\u3002<\/p>\n